/
/
/

Concord Drugs Balance Sheet

Consolidated
Standalone
%

Share Price Live Stats

Open (₹)80.90
Volume (₹)5,836.00
High (₹)82.50
Upper Circuit97.08
Low (₹)78.26
Lower Circuit64.72
Prev Close80.90
52W High (₹)92.52
Price79.68
52W Low (₹)61.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)106.59 Cr
Div. Yield (%)0.00
PE Ratio51.97
Debt to Equity0.56
Price to Book0.91
Book Value34.11
EPS (TTM)1.56
Face Value10.00
ROE (%)0.99

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMA-ANSE
DIVISLAB-ANSE
TORNTPHARM-ANSE
ZYDUSLIFE-ANSE
CIPLA-ANSE
LAURUSLABS-ANSE
AUROPHARMA-ANSE
DRREDDY-ANSE
LUPIN-ANSE
MANKIND-ANSE
CONCORD-XNSE
LTP
1W Low
1W High
Market cap (₹)
1842-57.8 (-3.04%)
1833.90
1907.35
4,47,236Cr
9326+21 (0.23%)
9109.80
10000
2,49,673Cr
4975+62 (1.26%)
4830
4999
1,87,460Cr
1119.5-35.5 (-3.07%)
1104.05
1167.20
1,11,521Cr
1365-30.95 (-2.22%)
1347.70
1397.05
1,11,484Cr
1970.35+102.1 (5.47%)
1826.95
1981.45
1,04,604Cr
1675.45+17.45 (1.05%)
1638.65
1703.25
96,031Cr
1161+16 (1.40%)
1131.05
1181.40
95,220Cr
2096-9 (-0.43%)
2060.55
2132.45
94,883Cr
2277-45.05 (-1.94%)
2221.10
2330
92,770Cr
79.68+1.59 (2.04%)
77.07
82.91
107Cr

Key Highlights of Concord Drugs Ltd Balance Sheet

Concord Drugs Ltd balance sheet discloses shareholders' funds of ₹10Cr as of 2025-03-31. The company’s equity share capital is at a value of ₹10Cr, and the reserves and surplus of the company is ₹24.11Cr.

The company has its non-current liabilities with total liabilities of ₹58.58Cr as of 2025-03-31.

The current liabilities are ₹19.62Cr as of 2025-03-31. At the same time, current assets are ₹33.42Cr as of 2025-03-31.

Key assets on the balance sheet are non-current investments of ₹1.61Cr and tangible assets of ₹11.54Cr, provided in the Concord Drugs Ltd financial statements.